OBJECTIVE: To develop insight into resident physician attitudes about inpatient hyperglycemia and determine perceived barriers to optimal management. METHODS: As part of a planned educational program, a questionnaire was designed and administered to determine the opinions of residents about the importance of inpatient glucose control, their perceptions about what glucose ranges were desirable, and the problems they encountered when trying to manage hyperglycemia in hospitalized patients. RESULTS: Of 70 resident physicians from various services, 52 completed the survey (mean age, 31 years; 48% men; 37% in first year of residency training). Most respondents indicated that glucose control was "very important" in critically ill and perioperative patients but only "somewhat important" in non-critically ill patients. Most residents indicated that they would target a therapeutic glucose range within the recommended levels in published guidelines. Most residents also said they felt "somewhat comfortable" managing hyperglycemia and hypoglycemia and using subcutaneous insulin therapy, whereas most residents (48%) were "not at all comfortable" with use of intravenous administration of insulin. In general, respondents were not very familiar with existing institutional policies and preprinted order sets relating to glucose management. The most commonly reported barrier to management of inpatient hyperglycemia was lack of knowledge about appropriate insulin regimens and how to use them. Anxiety about hypoglycemia was only the third most frequent concern. CONCLUSION: Most residents acknowledged the importance of good glucose control in hospitalized patients and chose target glucose ranges consistent with existing guidelines. Lack of knowledge about insulin treatment options was the most commonly cited barrier to ideal management. Educational programs should emphasize inpatient treatment strategies for glycemic control.
OBJECTIVE: To develop insight into resident physician attitudes about inpatient hyperglycemia and determine perceived barriers to optimal management. METHODS: As part of a planned educational program, a questionnaire was designed and administered to determine the opinions of residents about the importance of inpatient glucose control, their perceptions about what glucose ranges were desirable, and the problems they encountered when trying to manage hyperglycemia in hospitalized patients. RESULTS: Of 70 resident physicians from various services, 52 completed the survey (mean age, 31 years; 48% men; 37% in first year of residency training). Most respondents indicated that glucose control was "very important" in critically ill and perioperative patients but only "somewhat important" in non-critically ill patients. Most residents indicated that they would target a therapeutic glucose range within the recommended levels in published guidelines. Most residents also said they felt "somewhat comfortable" managing hyperglycemia and hypoglycemia and using subcutaneous insulin therapy, whereas most residents (48%) were "not at all comfortable" with use of intravenous administration of insulin. In general, respondents were not very familiar with existing institutional policies and preprinted order sets relating to glucose management. The most commonly reported barrier to management of inpatient hyperglycemia was lack of knowledge about appropriate insulin regimens and how to use them. Anxiety about hypoglycemia was only the third most frequent concern. CONCLUSION: Most residents acknowledged the importance of good glucose control in hospitalized patients and chose target glucose ranges consistent with existing guidelines. Lack of knowledge about insulin treatment options was the most commonly cited barrier to ideal management. Educational programs should emphasize inpatient treatment strategies for glycemic control.
Authors: Nestoras Mathioudakis; Peter J Pronovost; Sara E Cosgrove; Daniel Hager; Sherita Hill Golden Journal: Jt Comm J Qual Patient Saf Date: 2015-07
Authors: Rebecca D Wilson; Marilyn Bailey; Mary E Boyle; Karen M Seifert; Karla Y Cortez; Leslie J Baker; Michael J Hovan; Jan Stepanek; Curtiss B Cook Journal: J Diabetes Sci Technol Date: 2013-11-01
Authors: Rachel M Bailon; Curtiss B Cook; Michael J Hovan; Bryan P Hull; Karen M Seifert; Victoria Miller-Cage; Karen A Beer; Mary E Boyle; Stephanie D Littman; Janice M Magallanez; Joanne M Fischenich; Jana K Harris; Susie S Scoggins; Josephine Uy Journal: J Diabetes Sci Technol Date: 2009-03-01
Authors: Curtiss B Cook; Rebecca D Wilson; Michael J Hovan; Bryan P Hull; Richard J Gray; Heidi A Apsey Journal: J Diabetes Sci Technol Date: 2009-11-01
Authors: William B Horton; Sidney Law; Monika Darji; Mark R Conaway; Mikhail Y Akbashev; Nancy T Kubiak; Jennifer L Kirby; S Calvin Thigpen Journal: Endocr Pract Date: 2019-08-14 Impact factor: 3.443
Authors: Curtiss B Cook; Richard S Zimmerman; Susanne M Gauthier; Janna C Castro; Kimberly A Jameson; Stephanie D Littman; Janice M Magallanez Journal: J Diabetes Sci Technol Date: 2008-11